文传商讯
VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy
2020-12-22 12:14:03
Takeda Furthers Innovation-Focused Strategy in China with Sale of Select Non-Core Assets to Hasten f
2020-12-22 12:14:03
全球投资者法律顾问ROSEN提醒Raytheon Technologies Corporation(前称Raytheon Company)投资者注意RTX, R
2020-12-22 12:14:03
MyDataModels And Thales Selected by Nice Cte d’Azur Metropolitan Council to Develop BlueGuard Under
2020-12-22 12:14:03










